Cerecin

Denver, CO · Founded 2000 · Privately Held (backing)

Developer of therapeutics technology designed to treat memory impairment and other neurodegenerative diseases. Cerecin is based in Denver, CO and was founded in 2000. It has raised $317 million across 4 recorded rounds; the latest was a $3.7 million debt round in Jun 2024.

Last price · $/share
—
Implied valuation
—
Total raised
$316.7M
Last round
Debt
Jun 2024
Cap table — not yet on record

Cerecin's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Cerecin with a free account
  • ·The complete investor list: 12 names
  • ·Watch Cerecin: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Cerecin

Where does Cerecin's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Cerecin's 4 recorded funding rounds.